2026 Milestone The human trial the field has been waiting for February 2026 First Properly Designed Randomised Controlled Trial Now Recruiting Hudson Biotech began recruiting for the first randomised, placebo-controlled, blinded trial of BPC-157 in humans in February 2026 a Phase 2 study that represents the pivotal transition from preclinical to clinical evidence
Choudhury H, Gorain B, Karmakar S, Biswas E, Dey G, Barik R, et al
Unhealthy brains consistently have lower glutathione and higher markers of oxidative stress
Its lightweight, non-greasy texture absorbs comfortably into the skin while providing hydration without feeling heavy, making it ideal for daily skincare routines in Bangladeshs humid weather
Ordinary glutathione is broken down in the stomach before it reaches the cells, leaving little of it
Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity